Newton

Karyopharm Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress

Retrieved on: 
Mardi, août 6, 2019
Economy of New York City, NASDAQ, Kernel page-table isolation, Computer architecture, Computer engineering, Computing

ET

Key Points: 
  • ET
    NEWTON, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today reported financial results for the second quarter 2019.
  • XPOVIO Commercial Launch Underway in the U.S. On July 9, 2019, XPOVIO became commercially available to patients in the U.S.
  • Karyopharm expects research and development expense to be relatively consistent for the remainder of 2019 compared to the second quarter of 2019.
  • Karyopharm will host a conference call today, Tuesday, August 6, 2019, at 8:30 a.m. Eastern Time, to discuss the second quarter 2019 financial results, recent accomplishments, clinical developments and business plans.

Allena Pharmaceuticals to Present at 2019 Wedbush PacGrow Healthcare Conference

Retrieved on: 
Mardi, août 6, 2019

NEWTON, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced that Louis Brenner, M.D., Allenas President and Chief Executive Officer, will present a corporate overview at the 2019 Wedbush PacGrow Healthcare Conference on Tuesday, August 13, 2019 at 2:30 p.m.

Key Points: 
  • NEWTON, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced that Louis Brenner, M.D., Allenas President and Chief Executive Officer, will present a corporate overview at the 2019 Wedbush PacGrow Healthcare Conference on Tuesday, August 13, 2019 at 2:30 p.m.
  • A live audio webcast of the presentation will be available under Events and Presentations in the Investors section of the Companys website at www.allenapharma.com .
  • A replay of the webcast will be available on the Allena website for 30 days following the presentation.
  • Allena Pharmaceuticals, Inc.is a late-stage biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders.

MariMed Launches Hemp Engine™ Marketing Platform for CBD Distributors, Retailers and Consumers

Retrieved on: 
Lundi, août 5, 2019
Biofuels, Hemp, Herbs, Cannabis, CBD, Plants, Medicine, Applied sciences

Norwood, MA, Aug. 05, 2019 (GLOBE NEWSWIRE) -- MariMed Hemp, a subsidiary of MariMed , Inc. (OTCQB: MRMD), a leading multi-state cannabis and hemp operator focused on health and wellness, has launched the Hemp Engine, a turnkey retail marketing platform for the fast-growing CBD sector.

Key Points: 
  • Norwood, MA, Aug. 05, 2019 (GLOBE NEWSWIRE) -- MariMed Hemp, a subsidiary of MariMed , Inc. (OTCQB: MRMD), a leading multi-state cannabis and hemp operator focused on health and wellness, has launched the Hemp Engine, a turnkey retail marketing platform for the fast-growing CBD sector.
  • The Hemp Engine solution includes a complete store-within-a-store package, pre-stocked with a range of CBD products centered on a retailers particular criteria.
  • Hemp Engine creates powerful new distribution opportunities for our hemp-derived CBD brands, commented MariMed CEO, Robert Fireman.
  • According to Rick Granoff, co-founder of the Hemp Engine: The Hemp Engine addresses the major needs of retailers and consumers as CBD popularity and consumption continues to grow.

Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Retrieved on: 
Jeudi, août 1, 2019
Economy of New York City, NASDAQ, Economy of the United States, Finance, Industries

The stock options were granted as inducements material to the new employees entering into employment with Karyopharm in accordance with NASDAQ Listing Rule 5635(c)(4).

Key Points: 
  • The stock options were granted as inducements material to the new employees entering into employment with Karyopharm in accordance with NASDAQ Listing Rule 5635(c)(4).
  • Each of the stock options has an exercise price of$8.81 per share, the closing price of Karyopharms common stock on July 31, 2019.
  • Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an oncology-focused pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases.
  • A Marketing Authorization Application for selinexor is also currently under review by the European Medicines Agency.

Acer Therapeutics to Present at the 2019 Webush PacGrow Healthcare Conference

Retrieved on: 
Jeudi, août 1, 2019
Finance, Articles, Communication, Forward-looking statement, Money, Food and Drug Administration, Evidence, Risk, Standard & Poor's, Financial risk, Private Securities Litigation Reform Act

Acers product candidates are believed to present a comparatively de-risked profile, having one or more of a favorable safety profile, clinical proof-of-concept data, mechanistic differentiation and/or accelerated paths for development through specific programs and procedures established by the FDA.

Key Points: 
  • Acers product candidates are believed to present a comparatively de-risked profile, having one or more of a favorable safety profile, clinical proof-of-concept data, mechanistic differentiation and/or accelerated paths for development through specific programs and procedures established by the FDA.
  • This press release contains forward-looking statements that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995.
  • Such statements are based on managements current expectations and involve risks and uncertainties.
  • We disclaim any intent or obligation to update these forward-looking statements to reflect events or circumstances that exist after the date on which they were made.

From State Grant to Job Creation to Business Growth, Corporate Armor Flourishes In and With the City of Newton, North Carolina

Retrieved on: 
Mardi, juillet 30, 2019
Regions of the United States, Newton, North Carolina, Country subdivisions, United States

"Their investments in Newton are creating the technology workforce that will be so important to our community in the coming years.

Key Points: 
  • "Their investments in Newton are creating the technology workforce that will be so important to our community in the coming years.
  • I thank Luke Walling and Temprano Techvestors for supporting Newton and choosing to grow their business here," she continued.
  • Grants like these are awarded by the State of North Carolina to re-develop vacant buildings into assets that attract new or expanding businesses.
  • "The Building Reuse Grant Program continues to attract new companies to North Carolina," said Secretary of Commerce Anthony M. Copeland.

Garden Remedies Newton Opened Today for Adult Use Cannabis Sales, Launched "Seven East" Product Line

Retrieved on: 
Samedi, mai 25, 2019
Health sciences, Medicine, Health, Antiemetics, Antioxidants, Medical cannabis, Pharmaceuticals policy, Pharmacognosy, Newton

NEWTON, Mass., May 25, 2019 /PRNewswire/ -- Garden Remedies, Inc. (GRI), Massachusetts' only cannabis company founded and led by a woman physician, officially opened their Newton dispensary, located at 697 Washington Street, for adult use cannabis sales today, Saturday, May 25, 2019.

Key Points: 
  • NEWTON, Mass., May 25, 2019 /PRNewswire/ -- Garden Remedies, Inc. (GRI), Massachusetts' only cannabis company founded and led by a woman physician, officially opened their Newton dispensary, located at 697 Washington Street, for adult use cannabis sales today, Saturday, May 25, 2019.
  • Additionally, Garden Remedies launched a new line of their popular vape pens and cartridges.
  • "Today has been a very exciting first day serving adult use cannabis customers here at Garden Remedies in Newton," said Dr. Karen Munkacy, Founder, President and CEO, Garden Remedies, Inc. "As we anticipated, we have lots of happy clientle.
  • Prior to arriving at Garden Remedies Newton, visitors are required to book appointments through the company's website at GardenRemedies.com , their mobile app , or by calling Garden Remedies at 844-344-2420.

BabelBark Launches Alpha Pack, the Premium Upgrade to its Free BabelBark Application

Retrieved on: 
Mercredi, mai 1, 2019
Online marketplaces, Apple Inc., Software, Operating systems, Online music stores, App store, E-commerce, IOS, ITunes, Google Play, Newton

NEWTON, Mass., May 1, 2019 /PRNewswire-PRWeb/ -- BabelBark, Inc ., the only digital platform to connect everyone who cares for the health and wellness of a pet into one place, announces the launch of Alpha Pack, the premium upgrade to its free BabelBark application.

Key Points: 
  • NEWTON, Mass., May 1, 2019 /PRNewswire-PRWeb/ -- BabelBark, Inc ., the only digital platform to connect everyone who cares for the health and wellness of a pet into one place, announces the launch of Alpha Pack, the premium upgrade to its free BabelBark application.
  • Alpha Pack provides exceptional benefits for pet owners including 24-hour access to a veterinary helpline and a lost and found emergency response team.
  • Alpha Pack is a paid subscription service available through the BabelBark app.
  • The BabelBark app can be downloaded for free on the app store or on Google Play .

Newton Vineyard Opens Its Doors for the Journees Particulieres by LVMH

Retrieved on: 
Lundi, septembre 17, 2018
Economy of France, Luxury, Culture, Newton Vineyard, St. Helena, California, LVMH, Luxury brands, Antoine Arnault, Hennessy, Louis Vuitton, Newton

Newton Vineyard takes part in the Journes Particulires, a bi-annual event by the French luxury group LVMH Mot Hennessy Louis Vuitton, created in 2011 at the initiative of Antoine Arnault.

Key Points: 
  • Newton Vineyard takes part in the Journes Particulires, a bi-annual event by the French luxury group LVMH Mot Hennessy Louis Vuitton, created in 2011 at the initiative of Antoine Arnault.
  • To view the Multimedia News Release, please click: https://www.multivu.com/players/uk/8404151-newton-vineyard-for-journees-...
    The Journes Particulires are characterized by the discovery of heritage and savoir faire.
  • For the occasion, Newton - part of the LVMH group - has designed a 2-hour visit, including a vineyard tour.
  • "Les Journes Particulires is an opportunity for us to invite visitors to look behind the scenes, and share the history and the secrets of Newton Vineyard.